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The neonatal Fc receptor (FcRn) transports IgG across
epithelial cell barriers to provide maternal antibodies to
offspring and serves as a protection receptor by rescuing
endocytosed IgG and albumin from lysosomal degradation.
Here we describe the generation of polarized Madin–Darby
canine kidney (MDCK) cells expressing rat FcRn (rFcRn) to
investigate the potential requirement for ligand bivalency
in FcRn-mediated transport. The rFcRn-MDCK cells bind,
internalize and bidirectionally transcytose the bivalent
ligands IgG and Fc across polarized cell monolayers.
However, they cannot be used to study FcRn-mediated
transport of the monovalent ligand albumin, as we
observe no specific binding, internalization or transcyto-
sis of rat albumin. To address whether ligand bivalency
is required for transport, the ability of rFcRn to trans-
cytose and recycle wild-type Fc homodimers (wtFc; two
FcRn-binding sites) and a heterodimeric Fc (hdFc; one
FcRn-binding site) was compared. We show that ligand
bivalency is not required for transcytosis or recycling, but
that wtFc is transported more efficiently than hdFc,
particularly at lower concentrations. We also demon-
strate that hdFc and wtFc have different intracellular
fates, with more hdFc than wtFc being trafficked to
lysosomes and degraded, suggesting a role for avidity
effects in FcRn-mediated IgG transport.
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The plasma membranes of epithelial cell barriers are
segregated into two spatially and functionally distinct
domains that serve as a means for complex organisms
to distinguish between the external environment and the
underlying tissue. A vital characteristic of such cellular
barriers is their ability to selectively allow the passage of
materials, such as ions, small molecules, peptides, lipids
and proteins, either by passive or active (receptor medi-
ated) transport mechanisms. The neonatal Fc receptor
(FcRn), a class I major histocompatibility complex (MHC)-
related protein that associates with theMHC light chain b2-
microglobulin (b2m), mediates the transfer of maternal IgG
across epithelial cell barriers to the fetus or newborn (1,2).
In newborn suckling rodents, FcRn is expressed in the
polarized epithelium of the intestine. The FcRn present at
the apical surface of the intestinal cells binds to maternal
IgG from ingested milk, transcytoses it across the epithe-
lium and releases it into circulation from the basolateral cell
surface (1). This process confers passive humoral immu-
nity to the newborn during the first weeks of independent
life. The difference in pH between the intestinal lumen
(pH 6.0) and the bloodstream (pH 7.4) promotes the
efficient unidirectional transport of IgG, as FcRn binds IgG
at pH values 6.5, but not at neutral or higher pH (1,3).
The FcRn-mediated transport of IgG can also occur in the
absence of a pH gradient. In gestating primates, IgG in the
maternal bloodstream is transferred to the fetal blood-
stream in a process that consists of passive uptake of IgG
by syncitiotrophoblast cells, followed by transcytotic deliv-
ery to the fetal bloodstream on the opposite surface (4–6).
In adult mammals, FcRn plays a key role in serum IgG
homeostasis by protecting IgG taken up by vascular
endothelial cells from a default degradative pathway
(7–9). For both these functions, it is believed that IgG
internalized at pH 7.4 via fluid-phase endocytosis is bound
by FcRn in acidic endosomes. This results in FcRn–IgG
complexes being transcytosed in the case of maternofetal
IgG transfer, or returned to the cell surface rather than
catabolized in the case of serum IgG homeostasis.
We previously described a structure-based hypothesis to
account for the ability of cells to distinguish endosomes
containing FcRn–IgG complexes destined for recycling or
transcytosis from endosomes destined for a degradative
pathway (10). The hypothesis suggests that an oligomeric
ribbon of FcRn dimers bridged by the homodimeric Fc
regions of IgG molecules, as seen in the crystal structure
of an rFcRn/Fc complex (11), forms inside acidic trafficking
vesicles. Formation of the oligomeric ribbon between the
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adjacent membranes of a tubular endosome could act as
an intracellular trafficking signal, designating vesicles con-
taining such complexes for entry into the transcytotic or
recycling pathways. A requirement for the formation of the
oligomeric ribbon is a homodimeric Fc or IgG molecule
capable of bridging between FcRn proteins on opposing
membrane faces. Consistent with this hypothesis, pre-
vious studies demonstrated that a heterodimeric Fc mol-
ecule (hdFc), which contains one FcRn-binding chain and
one non-FcRn-binding chain, is less efficiently transcy-
tosed across neonatal mouse intestine (12) and exhibits
a shorter serum half-life (13) than a wild-type homodimeric
Fc molecule (wtFc). These results indicate that two FcRn-
binding sites on a ligand are required for the purposeful
movement of vesicles containing FcRn–ligand complexes
through the transcytotic and protection pathways. How-
ever, recent studies have demonstrated that human and
rodent FcRn bind amonomeric ligand, serum albumin, with
a similar pH dependency as the FcRn–IgG interaction, and
that mice lacking either the FcRn heavy or light chain
exhibit a shortened half-life for albumin in the circulation
(14,15). These studies support a model in which FcRn acts
as a protection receptor for a monomeric protein, albumin,
as well as for dimeric IgG and Fc ligands.
Here we describe an in vitro system using transfected
Madin–Darby canine kidney (MDCK) cells to compare the
transport of dimeric and monomeric FcRn ligands. The
MDCK cells expressing rat FcRn (rFcRn) transcytose Fc
and IgG in both the apical to basolateral and basolateral to
apical directions, consistent with previous studies of
human FcRn (hFcRn) and rFcRn expressed in MDCK cells
or other polarized cell lines (16–23). We do not observe
specific binding, uptake or transcytosis of a naturally
occurring monovalent FcRn ligand, rat albumin. We there-
fore used variant forms of rat Fc containing two, one or
zero FcRn-binding site (24) to assess the effects of ligand
valency on FcRn-mediated transport. We show that the
presence of two binding sites on the internalized Fc is not
strictly required for the transcytosis or recycling to occur,
but a bivalent Fc with two FcRn-binding sites (wtFc) is
trafficked more efficiently than its monovalent cognate
(hdFc), particularly at lower concentrations. Analysis by
confocal microscopy of wtFc and hdFc trafficking following
internalization reveals that the two ligands have different
intracellular fates such that more internalized hdFc than
wtFc colocalizes with markers for early endosomes (EEA1)
and lysosomes, consistent with quantitative studies dem-
onstrating that more hdFc than wtFc is degraded after
internalization. These results suggest that avidity effects
play a key role in FcRn-mediated ligand transport.
Results
Functional expression of rFcRn in MDCK cells
Our laboratory previously described the generation ofMDCK
cell lines expressing rFcRn and an rFcRn-green fluorescent
protein (GFP) chimeric protein (25). In the course of con-
ducting new experiments with the previously described
rFcRn-GFP-MDCK cell line, we discovered that we could
not replicate some of the published properties of the cell line
(26). It had been reported that the rFcRn-GFP-MDCK cells
functioned in transport of Fc when ligand was added at both
permissive (acidic) and nonpermissive (basic) pH values for
the rFcRn–IgG interaction and that rFcRn-GFP fluorescence
underwent a striking redistribution upon addition of ligand
at either pH (25). In recent experiments, however, we found
that the rFcRn-GFP-MDCK cell line, although positive by
antibody staining for both the rFcRn heavy and light chains
(data not shown), did not take up significant amounts of Fc or
IgG at basic pH, and the distribution of rFcRn-GFP did not
change upon ligand addition (26).
To resolve these discrepancies, we generated newMDCK
cell lines stably expressing rat b2m (rb2m) together with
the full-length rFcRn heavy chain or with an rFcRn-GFP
chimera in which GFP was added C-terminal to the rFcRn
cytoplasmic tail. Drug-resistant transfected cells were
screened by Western blot and by pH-dependent uptake
of fluorescent rat Fc. A drug-resistant cell line transfected
with an empty expression vector (vector-only MDCK) was
used as a negative control. The rFcRn-MDCK and rFcRn-
GFP-MDCK cells used in the present studies exhibited
transepithelial electrical resistance (TEER) values of250–
300 Vcm2 when grown as polarized monolayers on filter
supports. The high TEER value is important, as the rFcRn-
GFP-MDCK cell line described previously (25) was sub-
sequently found to have low TEER values (50–75 Vcm2),
consistent with our later finding that the cells were leaky
to radiolabeled ligands (our unpublished results).
Expression of rFcRn and rFcRn-GFP in the newly gener-
ated MDCK cell lines was verified in cell lysates by
Western blot. An anti-rFcRn antiserum detected two
bands migrating with apparent molecular masses of 50
and 65 kDa in the rFcRn-MDCK cell lysate and 80 and
95 kDa in the rFcRn-GFP-MDCK cell lysate (Figure 1A).
The upper and lower bands likely represent mature and
incompletely glycosylated forms of rFcRn, respectively, as
previously observed for hFcRn expressed in MDCK (16)
cells and rFcRn expressed in rat inner medullary collecting
duct (IMCD) cells (22). To verify IgG binding by rFcRn in
MDCK cells, whole-cell lysates were incubated with
human IgG-Sepharose beads at acidic or basic pH, and
the bound proteins were eluted and analyzed by Western
blot. The rFcRn and rFcRn-GFP were detected in IgG
pull-downs conducted at acidic but not at basic pH
(Figure 1B), although both proteins were detectable in
blots of total cell lysates from rFcRn-MDCK and rFcRn-
GFP-MDCK at both pH 6 and 8 (data not shown). Addition-
ally, no rFcRn or rFcRn-GFP is detected in IgG pull-downs
performed at pH 6 and subsequently washed at pH 8
(data not shown), demonstrating that both forms of
rFcRn bind IgG at pH 6 and dissociate from the ligand at
pH 8.
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Confocal analyses of rFcRn-MDCK and rFcRn-GFP-MDCK
cells showed intracellular compartments that are labeled
by antibodies against the heavy and light chains of rFcRn
(Figure 1C). The stainings for rFcRn and rb2m are colocalized,
consistent with proper association between the two
chains, and both the anti-rFcRn and the anti-rb2m fluores-
cence colocalize with GFP fluorescence in the rFcRn-GFP-
MDCK cell line, indicating that GFP can be used as amarker
for rFcRn expression in this cell line.
The ability of rFcRn-MDCK and rFcRn-GFP-MDCK cells to
uptake wtFc, a recombinant rat Fc (24), was evaluated by a
quantitative radioligand endocytosis assay. As shown in
Figure 2, rFcRn-MDCK and rFcRn-GFP-MDCK cells internal-
ized a significant amount of [125I]wtFc at pH 6 but not at pH 8.
Internalization was saturable, as inclusion of the unlabeled
wtFc or IgG reduced the uptake to background levels, and
was also specific, as significant uptake of a recombinant
rat Fc with substitutions in both chains that prevent binding
to rFcRn (nonbinding Fc; nbFc) (24) was not observed in
either the rFcRn-MDCK or the rFcRn-GFP-MDCK cells.
Labeled hdFc, a recombinant rat Fc composed of one wild-
type Fc chain and one nbFc chain (24), was also endo-
cytosed by the rFcRn-MDCK cells in a saturable and
pH-dependant manner, although at lower levels than wtFc
(Figure 2). Taken together, these results show that rFcRn
expressed in MDCK cells undergoes proper posttransla-
tional modifications, binds IgG with the expected pH
dependence and mediates specific and saturable uptake
of Fc ligands at acidic pH.
To observe the subcellular localization of endocytosed Fc,
the apical surfaces of polarized rFcRn-MDCK, rFcRn-GFP-
MDCK or vector-only MDCK cell monolayers were incu-
bated with wtFc (1 mM) at acidic or basic pH and processed
for immunofluorescence microscopy. Confocal images
Figure 1: Expression of rFcRn and rFcRn-GFP in MDCK cells. (A) Western blot using anti-rFcRn antiserum of detergent lysates from
rFcRn-MDCK, rFcRn-GFP-MDCK and vector-only MDCK cells. Two bands, likely representing the mature and incompletely glycosylated
rFcRn heavy chains, are detected in rFcRn-expressing cells, but not in control cells. (B) Western blot of detergent lysates after a pull-down
with human IgG-Sepharose at pH 6 or pH 8. Bands corresponding to the rFcRn and rFcRn-GFP heavy chains are present in samples from pull-
downs at pH 6. No bands are detected in samples pulled down at pH 6 and subsequently washed at pH 8 (data not shown). (C) Confocal
images of rFcRn-MDCK and rFcRn-GFP cells stained with fluorescently labeled anti-rFcRn (green or blue) or anti-rb2m (red) antibodies.
Staining of rFcRn-MDCK cells shows that rFcRn-positive compartments colocalize with rb2m-positive compartments, and staining of rFcRn-
GFP-MDCK cells shows that fluorescence from GFP colocalized with fluorescence from both the anti-rFcRn and anti-rb2m antibodies.
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(Figure 3) show that internalized wtFc (red fluorescence) is
present in rFcRn-positive compartments (green fluores-
cence) in rFcRn-MDCK and rFcRn-GFP-MDCK cells incu-
bated with ligand at pH 6. The distribution of rFcRn and
rFcRn-GFP was not significantly different in the absence of
wtFc or IgG compared to when these ligands were present
at concentrations ranging from 20 nM to 1 mM (data not
shown), contradicting the previous report (25). Also in
contrast to the previous study (25), substantially less
uptake was observed when the cells were incubated with
wtFc at basic pH (pH 7.4) versus at acidic pH (shown for
rFcRn-MDCK; Figure 3), indicating that an acidic extracel-
lular environment greatly enhances uptake by allowing Fc
to bind rFcRn at the cell surface prior to internalization. The
vector-only MDCK cells did not stain with the 1G3 antibody
and showed only low levels of internalized wtFc (Figure 3),
likely resulting from trace internalization via the fluid phase.
Bidirectional transcytosis of IgG and Fc
Radiolabeled rat wtFc (20 nM) was added to the apical
surface of the polarized rFcRn-MDCK or rFcRn-GFP-MDCK
monolayers at pH 6, while the basolateral surface was
maintained at pH 8. The amount of transcytosed ligand in
the basolateral reservoir was measured after 90 min.
Significantly more wtFc is transported by the rFcRn-MDCK
cells than the control MDCK cells (Figure 4A). The pres-
ence of a 500-fold excess of competitor (unlabeled rat IgG
or wtFc) reduces transcytosis to background levels ob-
served for [125I]nbFc.
Surprisingly, rFcRn-GFP-MDCK cells do not mediate spe-
cific transport of [125I]wtFc (Figure 4A). This lack of detect-
able transport was observed in at least three other clones
of rFcRn-GFP-MDCK cells, and in transcytosis experi-
ments performed in both the apical to basolateral and
basolateral to apical directions (data not shown). Because
the rFcRn-GFP-MDCK cells do appear to function in a pH-
dependent uptake of wtFc (Figure 2), these data suggest
that addition of the GFP tag to the rFcRn cytoplasmic tail
does not prevent endocytosis, but interferes with post-
internalization trafficking events. Further experiments
were therefore conducted using only the rFcRn-MDCK
cells and vector-only control MDCK cells.
We next compared the ability of rFcRn-MDCK cells to
transcytose IgG and Fc ligands in both the apical to baso-
lateral and basolateral to apical directions (Figure 4B). These
experiments were conducted using [125I]human IgG and
[125I]human Fc because radiolabeled human IgG is trans-
cytosed more efficiently than radiolabeled versions of other
commercially available IgGs (data not shown). We find that
both IgG and Fc are transcytosed bidirectionally across the
rFcRn-MDCK cells when the loading surface is maintained
at pH 6 and the nonloading surface is maintained at pH 8
(Figure 4B). When either ligand is prevented from binding to
cell-surface rFcRn bymaintaining the loading surface at pH 8,
or by saturating surface receptors with unlabeled ligand,
we see only background levels of transcytosis. Fc is
transported more efficiently than intact IgG in both direc-
tions. The lower efficiency of IgG transcytosis as com-
pared with Fc transcytosis may result from steric effects,
i.e., the Fab arms present on intact IgG could clash with the
membrane when rFcRn is in a ‘standing up’ conformation
(11). This is consistent with our observation that intact rat
IgG competes less efficiently for endocytosis and trans-
cytosis of [125I]wtFc than does wtFc (Figures 2 and 4A).
Binding, endocytosis and transport studies using
rat albumin as an rFcRn ligand
IgG and Fc are both bivalent ligands of FcRn, that is, each
contains two potential FcRn-binding sites. To determine
whether rFcRn expressed in MDCK cells can act as
a functional receptor for a monovalent ligand, rat serum
albumin (RSA), we conducted binding, endocytosis and
transcytosis assays using [125I]RSA. Because RSA has
a more acidic pH optimum than IgG for binding to rFcRn
(14,27), cell-surface binding assays were performed at pH
5.0. Although rFcRn-MDCK cells incubated at pH 5 specif-
ically bind [125I]wtFc (data not shown), cells incubated with
[125I]RSA and then washed at pH 5 do not bind more RSA
than cells washed at pH 8 (Figure 5A); thus, we see no
specific binding of RSA to rFcRn-MDCK cells.
Wenext tested the possibility that binding to cell-surface rFcRn
that is undetectable in a binding assay could promote endocy-
tosis of RSA into rFcRn-MDCK cells. A high concentration
(3 mM) of [125I]RSAwas added at pH 5 or 8 to rFcRn-MDCK or
to vector-onlyMDCK cells in the presence or absence of a 100-
fold excess of unlabeled RSA. We find that both the rFcRn-
MDCK and vector-only cells internalize a high level of labeled
RSA at pH 5 and at pH 8, with the greatest amount of
internalization being observedwhen [125I]RSA is added at pH 5
without competitor (Figure 5B). Although slightly more RSA is
internalized at pH 5 by the rFcRn-MDCK cells than by the
vector-onlyMDCK cells, perhaps representing rFcRn-mediated
endocytosis of RSA, the difference is very small compared to
the absolute amount of RSA internalized by either cell line.
We also investigated whether the rFcRn-MDCK cells can
transcytose RSA. To account for the relatively low affinity
of the RSA–rFcRn interaction (14,27), a high concentration
of [125I]RSA (10 mM) was incubated at the apical surface of
Figure 2: Endocytosis of rFcRn ligands by rFcRn and rFcRn-
GFP expressed in MDCK cells. Subconfluent rFcRn-MDCK,
FcRn-GFP-MDCK or vector-only MDCK were incubated with
radiolabeled Fc ligands (recombinant wtFc, hdFc and nbFc derived
from rat IgG2a at a concentration of 20 nM) at pH 6 or pH 8 in the
presence or absence of a 500-fold excess of unlabeled competitor
protein, and levels of radioactivity were determined in cell lysates.
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Figure 3: Distribution of internalized wtFc in rFcRn-MDCK, rFcRn-GFP-MDCK and vector-only MDCK cells. Filter-grown mono-
layers were incubated with 1 mM wtFc (recombinant Fc derived from rat IgG2a) for 1 h at pH 6 or pH 7.4 and processed for immuno-
fluorescence using antibodies against wtFc (red) and the tight junction marker ZO-1 (blue). The heavy chain of rFcRn (green) was detected
using GFP fluorescence (rFcRn-GFP-MDCK cells) or an antibody against the rFcRn heavy chain (rFcRn-MDCK and vector-only MDCK cells).
Optical sections were taken every 2 mm below the level of the tight junctions.
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rFcRn-MDCK or vector-only-MDCK cells at pH 5 or pH 8.
Control experiments using labeled wtFc and nbFc demon-
strated that incubation at pH 5 does not disrupt trans-
cytosis of a functional ligand (wtFc) or result in leakage of
nbFc across the monolayer (Figure 5C). In the experiments
using labeled RSA, we see no evidence of rFcRn-mediated
transcytosis. Instead, we observe a high level of transport
across both the rFcRn-MDCK and control cells at both
acidic and basic pH, with transport being slightly higher for
both cell lines at basic pH (Figure 5C). Similar results were
obtained in experiments using lower concentrations of
[125I]RSA (data not shown). The lack of observed trans-
cytosis of RSA in the rFcRn-MDCK cells is consistent with
a previous demonstration that little or no albumin is trans-
cytosed across the proximal intestine of neonatal rats
under conditions in which 10–35% of the administered
IgG is transported into the blood (28).
Relative affinities of wtFc and hdFc
for cell-surface rFcRn
Because we did not observe binding or transyctosis of
albumin, a naturally occurring monovalent ligand for FcRn,
Figure 4: Bidirectional transcytosis of Fc and IgG ligands by rFcRn-MDCK cells. Radiolabeled Fc or IgG was added to the loading
surface (apical in panel A and apical or basolateral in panel B) of polarized cell monolayers and levels of radioactivity in the media from the
nonloading surface were measured after 90 min. Bars represent the mean and standard deviation of triplicate filters. (A) Comparison of
apical to basolateral transcytosis of wtFc in three different cell lines. rFcRn-MDCK, rFcRn-GFP-MDCK and vector-only MDCK cells were
incubated on the apical surfacewith 20 nM of [125I]wtFc (recombinant Fc derived from rat IgG2a), [125I]wtFc plus 500-fold excess unlabeled
wtFc or rat IgG (rIgG), or [125I]nbFc. (B) Comparison of bidirectional transcytosis of Fc and IgG. rFcRn-MDCK and vector-only MDCK cells
were incubated with 20 nM [125I]human Fc (hFc) or [125I]human IgG (hIgG) on the apical or basolateral surface. Control experiments were
performed in the presence of 500-fold excess unlabeled hFc or at pH 8 as indicated.
1132 Traffic 2006; 7: 1127–1142
Tesar et al.
we used hdFc as a monovalent ligand for comparative
studies with wtFc, a bivalent ligand. We first compared the
binding of radiolabeled wtFc and hdFc to rFcRn on the
surface of rFcRn-MDCK cells. Equilibrium dissociation con-
stants (KD) were determined by nonlinear regression analy-
sis from plots of bound Fc as a function of Fc concentration
(Figure 6A). The wtFc binding data were fit to a two-site
bindingmodel assuming two independent classes of binding
sites (a high-affinity class, which takes avidity effects into
account, and a low-affinity class), yielding KD values of 1.6
and 13 nM. The hdFc binding data cannot be fit to a two-site
binding model (data not shown), consistent with its single
FcRn-binding site. These data were therefore fit to a 1:1
binding model, from which a KD of 120 nM was derived.
Transcytosis and recycling efficiencies
of monovalent and bivalent Fc proteins
We next compared the transcytosis and recycling efficien-
cies of the two forms of rat Fc. First, radiolabeled versions
of wtFc and hdFc were added at pH 6 to the apical surface
of rFcRn-MDCK monolayers at a range of concentrations.
The amount of transcytosed Fc released into the basolateral
medium after 90 min was plotted as a function of Fc
concentration (Figure 6B), yielding curves that are analo-
gous to the binding isotherms in Figure 6A. At concentra-
tions below 1 mM, wtFc is transported in significantly
greater amounts than hdFc. Transcytosis of both proteins
is comparable at approximately 1 mM, and for values greater
than 1 mM, more hdFc than wtFc is transported to the
basolateral media. Nonlinear regression analysis performed
on the trancytosis data was used to extract the concentra-
tion at which half-maximal transcytosis occurs (T1/2max),
which is analogous to a KD, the concentration at which half-
maximal binding of a ligand to its receptor occurs. As
described for the binding data, the wtFc transcytosis data
were fit to a two-site model, yielding two T1/2max values,
5.2 nM (high-affinity population) and 26 nM (low-affinity
population), and the data for hdFc were fit to a one-site
model, yielding a single T1/2max value (1.6 mM). The fact
that the T1/2max value for the high-affinity population of
receptors that bind wtFc (5.2 nM) is lower than the T1/2max
value for hdFc (1.6 mM) indicates that bivalency of the Fc
ligand contributes to the efficient transcytosis of cargo,
particularly at lower ligand concentrations, but that ligand
bivalency is not absolutely required for FcRn-mediated
transcytosis.
Figure 5: Albumin binding, endocytosis and transport experiments. (A) Cell-surface binding. rFcRn-MDCK cells were incubated at pH 5
with [125I]RSA at a range of concentrations. For each concentration of labeled RSA, quadruplicate samples were washed at either pH 8 or
pH 5 after the incubations, and the radioactivity bound at basic pH was subtracted from the radioactivity bound at acidic pH to determine
the amount of specifically bound RSA at each concentration. (B) Endocytosis of RSA. Subconfluent rFcRn-MDCK and vector-only MDCK
cells were incubated with 3 mM [125I]RSA at pH 5 in the presence or absence of 2 mM unlabeled RSA, or at pH 8, and levels of radioactivity
were determined in cell lysates. (C) Apical to basolateral transcytosis of RSA. The apical surfaces of filter-grown cell monolayers were
incubated with 10 mM [125I]RSA at pH 5 or pH 8 as indicated. Some filters were treated with 30 nM [125I]wtFc or [125I]nbFc as positive and
negative controls, respectively. The levels of radioactivity in the basolateral media were determined after 90 min.
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Apical recycling was evaluated by measuring the amount
of radioligand returned to the apical media after internali-
zation from the apical surface of rFcRn-MDCK cells. As
described for the transcytosis assay, the amounts of
recycled wtFc and hdFc were plotted as a function of
concentration, and the concentrations at which half-
maximal recycling occurs (R1/2max) were determined from
the data by nonlinear regression analyses using a two-site
Figure 6: Comparison of binding and transport of wtFc and hdFc by rFcRn-MDCK cells. Binding, transcytosis and recycling data are
presented separately for wtFc and hdFc (recombinant Fc proteins derived from rat IgG2a) as a linear function of concentration (left and center
graphs in panels A–C), and together as a function of the logarithm of the input concentration (right graphs in panels A–C). Data points represent
the mean and standard error for quadruplicate (panel A) or triplicate (panels B and C) measurements. The data for wtFc were fit to a two-site
binding model, therefore yielding two half-maximal values per graph: half-maximal binding (KD), half-maximal transport (T1/2max) or half-maximal
recycling (R1/2max). The data for hdFc were fit to a one-site binding model, yielding one half-maximal value per graph (see Materials and
Methods). (A) Cell-surface binding of wtFc and hdFc. The amounts of wtFc and hdFc bound to cell-surface rFcRn were determined using
500 000 cells at each input concentration. Assuming that each wtFc or hdFc molecule is bound by a single rFcRn molecule at saturating
concentrations, there are 150 fmol of ligand binding sites in each binding experiment, which corresponds to 180 000 surface-accessible
sites/cell. (B) Apical to basolateral transcytosis of wtFc and hdFc. (C) Apical recycling of wtFc and hdFc. (D) Comparison of T1/2max to KD and
R1/2max to KD ratios for wtFc and hdFc. These ratios are predicted to be 1.0 in a perfectly efficient transport or recycling system.
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Figure 7: Comparisonof intracellular localization anddegradationofwtFc andhdFc. (A andB) The apical surface of rFcRn-MDCKcellswas
incubated with 1 mMwtFc or hdFc (recombinant Fcs derived from rat IgG2a) at pH 6 for 1 h, then fixed and processed for immunofluorescence
using labeled antibodies against rat Fc and specific markers. The degree of colocalization of the Fcs with EEA1 (panel A) or LAMP-2 (panel B) is
shown as a function of distance from the apical pole on the left of each panel (n ¼ 3 or 4 for each data point). The percentage of above-
threshold Fc pixels colocalizing with above-threshold EEA1 or LAMP-2 pixels was determined in each optical section as described in the
Materials and Methods. Confocal images of the distributions of wtFc or hdFc (green) and EEA1 (red) (panel A) or wtFc or hdFc (green) and
canine LAMP-2 (red) (panel B) are shown for a subapical optical section on the right of each panel. Regions of colocalization appear yellow in
the merged images. (C) Averages of the colocalization coefficients for five optical sections spanning the whole cell. Significantly more
(p < 0.0001) hdFc than wtFc colocalizes with EEA1 (n ¼ 15 and n ¼ 19, respectively) and with LAMP-2 (n ¼ 20). (D) Comparison of
degradation of wtFc and hdFc. [125I]labeledwtFc or hdFcwas internalized at pH 6 from the apical surface of rFcRn-MDCK cells for 1 h, after
which the cells were washed at pH 8. The cells were returned to 378C for the indicated time points, after which acid-soluble radioactivity in
the media was measured. The percent of each Fc that was degraded was determined as described in the Materials and Methods.
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binding model (wtFc) or a one-site binding model (hdFc)
(Figure 6C). The R1/2max values for recycling of wtFc
(R1/2max1) and hdFc are 22 nM and 3.3 mM, respectively,
indicating that bivalency of the Fc ligand also contributes to
the efficiency of the recycling process.
To compare the affinities of the two forms of Fc to their
transport efficiencies, we calculated the T1/2max/KD and
R1/2max/KD ratios for each Fc. For comparisons of wtFc
transcytosis and recycling with binding, we are interested
in the KD, T1/2max and R1/2max values representing the high-
affinity population of receptors that are affected by avidity
(KD1, T1/2max1 and R1/2max in Figure 6A–C). The T1/2max1/KD1
ratio for wtFc is 3.2, which is significantly smaller than the
T1/2max/KD ratio for hdFc (~14) (Figure 6D); thus, the less
efficient transport of hdFc versus wtFc is not fully explained
by the differences in affinity. Similarly, the R1/2max1/KD1
ratio for wtFc (~14) is smaller than the R1/2max/KD ratio for
hdFc (~28) (Figure 6D).
Although the T1/2max and R1/2max values demonstrate that
higher concentrations of hdFc than wtFc are required to
achieve half-maximal transcytosis or recycling rates, the
absolute amounts of hdFc that are transcytosed and
recycled are higher than the analogous amounts of wtFc
as the concentration of Fc approaches saturation (values
above 1 mM) (Figure 6B,C). The reason for the higher
levels of hdFc transport is unclear. It may result from the
fact that a given number of receptors can transport twice
as many hdFc molecules as wtFc because hdFc can be
bound and transported by only one receptor, whereas
wtFc can be bound and transported by two receptors. In
addition, allowing each receptor to act as an independent
trafficking unit may increase the overall rate at which
individual receptors can complete one full round of ligand
internalization and transport as compared to when the
receptors are required to transport cargo in sets of two.
Comparison of localization of wtFc and hdFc
in rFcRn-MDCK cells
To address whether the increased efficiency of wtFc over
hdFc transport results from different intracellular fates of
the two forms of Fc, we compared the intracellular local-
izations of internalized wtFc and hdFc with a marker for
early endosomes (EEA1) and with a marker for lysosomes
(the lysosomal membrane protein LAMP-2).
After 1 h of internalization from the apical surface, both
wtFc and hdFc are present in discrete compartments
throughout the cell (Figure 7A,B), including EEA1-positive
compartments (Figure 7A), demonstrating that rFcRn-
bound Fc proteins enter the endosomal network after being
endocytosed. Although the mean intensity of the wtFc and
hdFc staining is similar (see Materials and Methods), more
hdFc than wtFc is colocalized with EEA1, as demonstrated
by quantitative analysis of the confocal image data to
determine the percent colocalization of above-threshold
fluorescence for each type of Fc with EEA1 (see Materials
andMethods). The degree of hdFc colocalization with EEA1
is consistently higher throughout the cell than the colocal-
ization of wtFc with EEA1, with the most significant differ-
ences observed in the apical sections of the monolayer
(left, Figure 7A). Averaged over the entire cell, 64  3.0%
of the hdFc fluorescence colocalizes with EEA1-positive
compartments compared with 49  1.4% of the wtFc
fluorescence (Figure 7C). A more striking difference is
observed for colocalization of the two Fcs with the lyso-
somal marker LAMP-2 (Figure 7B), in which 59  2.8% of
hdFc fluorescence colocalizes with LAMP-2-positive com-
partments compared with 34  1.7% of wtFc fluorescence
(Figure 7C).
The observation that more hdFc than wtFc is present in
LAMP-2-positive compartments suggests that more hdFc
than wtFc is degraded following internalization. To test this
possibility, we measured the amounts of degraded Fc
(acid-soluble radioactivity) released as a function of time by
cells incubated with 1 mM wtFc or hdFc. As shown in
Figure 7D, more degraded radioligand is released from
hdFc-treated cells than from wtFc-treated cells. This
difference is significant for postincubation times of
30 min or more, confirming that a substantially greater
fraction of a single cohort of internalized hdFc is degraded
compared to wtFc.
Discussion
Ligand valency is a critical feature of many receptor–ligand
interactions. While many receptors that mediate intracel-
lular signal transduction bind bivalent ligands to form 2:1
receptor:ligand complexes (e.g., platelet-derived growth
factor receptor, colony-stimulating factor 1 receptor and
stem cell factor receptor) [reviewed by Heldin (29)],
receptors involved in ligand transcytosis and transport
more commonly bind monovalent ligands to form 1:1
complexes (e.g., pIgR, low-density lipoprotein receptor
and transferrin receptor) [reviewed by Tuma and Hubbard
(30)]. FcRn was first identified as a receptor for IgG,
a bivalent ligand, and the crystal structure of rFcRn in
complex with wtFc showed that two FcRn molecules can
bind simultaneously to a dimeric Fc (11). Studies of purified
proteins in solution confirmed a 2:1 FcRn:Fc stoichiometry
(24,31–33), and in vivo studies in mice showed that both
FcRn-binding sites on Fc are required for efficient trans-
cytosis and protection from catabolism (12,13). However,
the discovery that FcRn also serves as a protection re-
ceptor for serum albumin (14,34), a monovalent ligand,
suggests that ligand bivalency is not a general requirement
for FcRn-mediated ligand trafficking.
Here we investigate the effects of valency on FcRn-
mediated ligand trafficking to determine whether bivalency
of an FcRn ligand is a strict requirement for proper
trafficking, or if it merely acts to increase the efficiency
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of the trafficking process. In the former case, one would
expect the binding of the Fc or IgG ligand by two FcRn
molecules to act as a signal, perhaps by bringing the
receptors into close spatial proximity to facilitate interac-
tions with cytosolic trafficking components. In the latter
case, the binding of each ligand by two receptors would
facilitate transport through an avidity effect, ensuring that
the ligand molecule, once bound and internalized, remains
in complex with its receptor throughout the transport
process.
To evaluate the effects of ligand valency on FcRn-mediated
transport, we generated stable MDCK cell lines expressing
rFcRn that can be used as a model system for studies of
FcRn-mediated transport of IgG and Fc ligands. Two cell
lines were generated: rFcRn-MDCK, which expresses full-
length rFcRn and the rFcRn light chain rb2m, and rFcRn-
GFP-MDCK, which expresses an rFcRn-GFP chimeric
protein together with rb2m. The expressed rFcRn proteins
both bind to IgG at acidic but not at basic pH (Figure 1B),
the characteristic pH dependency of the FcRn–IgG inter-
action (3). Functional binding and internalization of Fc
ligands were demonstrated in polarized rFcRn-MDCK and
rFcRn-GFP-MDCK monolayers at acidic pH (Figure 2). We
observe only background amounts of wtFc internalized
at pH 8, suggesting that fluid-phase uptake at basic pH is
not significant at the relatively low concentration (20 nM)
used for these experiments. Thus, an acidic extracellular
environment greatly enhances the efficiency of ligand
uptake, most likely by allowing IgG or Fc to bind rFcRn
molecules transiently exposed to the cell surface prior
to reinternalization. However, confocal analyses of rFcRn-
MDCK cells that have internalized Fc ligands at a sig-
nificantly higher concentration (1 mM) indicate that a low,
but detectable, amount of wtFc is internalized at pH
7.4 (Figure 3), consistent with the assumption that non-
receptor-mediated uptake of IgG at basic pH occurs in
FcRn-mediated placental transport and in FcRn-mediated
recycling of IgG by vascular endothelial cells (35). In these in
vivo situations, the high concentration of IgG in the blood
(50–100 mM) (36) likely facilitates fluid-phase uptake of IgG.
The rFcRn-MDCK cells transport IgG and Fc in both
the apical to basolateral and basolateral to apical direc-
tions when the loading surface is incubated at acidic pH
(Figure 4) as previously observed for hFcRn-transfected
MDCK cells (16–18), rFcRn-transfected IMCD cells (20–22)
and rat alveolar cells (23). Interestingly, in contrast to the
studies on hFcRn in MDCK cells, in which higher levels of
transcytosis occurred in the basolateral to apical direction
(16,17), rFcRn expressed in IMCD and rat alveolar cells
transports more ligand in the apical to basolateral direction
(20,23). Consistent with these results, the rFcRn-MDCK
cells described here transport more Fc in the apical to
basolateral direction and roughly equal amounts of IgG
bidirectionally (Figure 4), suggesting fundamental differ-
ences in the preferred directionality of ligand transport by
the rat and human receptors.
Although the rFcRn-MDCK cells function in transcytosis of
IgG and Fc ligands, we do not observe significant levels of
wtFc transport in the rFcRn-GFP-MDCK cells (Figure 4A).
The most likely explanation is that the addition of GFP to
the C-terminus of the rFcRn cytoplasmic tail interferes
with the binding of downstream effectors responsible for
mediating intracellular trafficking processes. This is sur-
prising, as a C-terminal GFP fusion of hFcRn has been
shown to function in recycling of IgG ligands in the human
endothelial cell line HMEC-1.CDC (35,37). Whether this
discrepancy is due to differences in the interactions
required for transcytosis versus recycling, differences in the
behavior of the receptors when expressed in HMEC-1.CDC
versus MDCK cells or fundamental differences between
the hFcRn and rFcRn proteins is not clear. However, the
fact that rFcRn-GFP-MDCK cells function in specific uptake
of Fc ligands (Figure 2) suggests that signals responsible
for endocytosis are intact, implying different signalingmech-
anisms for endocytosis versus transcytosis, or that rFcRn
can internalize bound ligand via non-specific membrane
flow after binding to ligand molecules at the cell surface.
Having demonstrated that rFcRn expressed in MDCK cells
functions in binding, endocytosis and transcytosis of Fc
and IgG ligands, both of which are naturally bivalent, we
sought to study the interaction of rFcRn with RSA, a mono-
valent ligand that binds to rFcRn with the same pH
dependency as the FcRn–IgG interaction and for which
FcRn acts as a protection receptor in vivo (14,34). Despite
using high ligand concentrations (10 mM) and low pH (pH 5)
to facilitate binding (14,27), we were not able to detect
specific binding of radiolabeled RSA to rFcRn (Figure 5A).
We note, however, that although the experiments were
performed at concentrations near or above the KD of
hFcRn for albumin (1–5 mM) (27), we could not perform
experiments at the concentration of albumin in serum
(270 mM) (38) because of background problems. When
incubated at 3 mM, rFcRn-MDCK cells did not internalize
significantly more RSA than control cells that do not
express rFcRn (Figure 5B). However, both cell lines inter-
nalized less labeled RSA in the presence of competing
unlabeled RSA, suggesting that much of the observed
internalization was due to non-rFcRn-dependent binding
of the labeled RSA to constituents of the cell surface. In
addition, the levels of apical to basolateral transport of
labeled RSA were similar in rFcRn-expressing and control
cell lines, and the degree of transport was not significantly
altered in either cell line by incubating the loading surface
at pH 8 rather than at pH 5 (Figure 5C). Taken together,
these results suggest that RSA binds non-specifically to
components present on the surface of MDCK cells; thus,
these cells are not an appropriate system in which to study
the interaction of rFcRn with RSA.
To investigate the potential requirement for two FcRn-
binding sites on an FcRn ligand, we compared the ability
of rFcRn-MDCK cells to transcytose and recycle mono-
valent and bivalent forms of rat Fc (hdFc and wtFc, which
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contain one and two FcRn-binding sites, respectively)
(Figure 6B,C). The experiments were performed over
a wide range of concentrations (0.15 nM–10 mM) to com-
pensate for avidity affects that favor binding of wtFc over
hdFc at low concentrations. The results revealed that hdFc
is specifically transcytosed and recycled by rFcRn, but that
more wtFc than hdFc is transported at low concentrations
(<1 mM). Previous studies suggesting that two FcRn-
binding sites on mouse Fc are required for FcRn-mediated
rescue from catabolism (13) and transcytosis across the
intestine of neonatal mice (12) are consistent with the
present results if the Fc concentrations used in the in vivo
studies fell within the range in which wtFc is more
efficiently transported by FcRn than hdFc. The present
study reveals that the amount of wtFc transcytosed
reaches a relatively constant level at concentrations above
150 nM, whereas the amount of hdFc transcytosed con-
tinues to increase with concentration, such that more hdFc
than wtFc is transcytosed at concentrations above 1 mM
(Figure 6B). At a concentration of 10 mM, at least twice as
much hdFc is transcytosed or recycled as wtFc. This
suggests that two rFcRn molecules are bound to each
wtFc during the transport process, whereas only one
rFcRn molecule is bound to each hdFc, resulting in twice
as many available receptors to transport the monovalent
hdFc as there are for the transport of the bivalent wtFc.
To determine how the differences in rFcRn-mediated
transport of wtFc versus hdFc are related to the apparent
affinity of rFcRn for each ligand, we compared the con-
centrations of each protein that result in half-maximal
binding to cell-surface rFcRn (KD) with the concentrations
that result in half-maximal transcytosis across a polarized
monolayer (T1/2max) and with the concentrations that result
in half-maximal recycling of ligand back to the apical
surface (R1/2max). In a perfectly efficient transcytosis
system, each binding event would result in a single trans-
cytosis event, and T1/2max would equal KD. In the present
study, we observe that the T1/2max/KD ratio for wtFc
transcytosis is 3, whereas the ratio for hdFc transcytosis
is 14 (Figure 6D). For the recycling experiments, the
R1/2max/KD ratio for wtFc is14, whereas the ratio for hdFc
is28. Thus, a greater number of individual binding events
result in successful transcytosis or recycling of the bivalent
wtFc, whereas transcytosis or recycling of the monovalent
hdFc requires the input of more ligand to achieve satura-
tion of the transport system. Interestingly, the T1/2max/KD
and R1/2max/KD values suggest that a given Fc molecule,
once bound to FcRn at the apical surface, is more likely to
be transcytosed than recycled.
The observed differences in the relative efficiencies of
transport of the bivalent and monovalent Fcs could be
related to differences in the subcellular fates of the two
molecules during rFcRn-mediated trafficking. For example,
a higher proportion of endocytosed hdFc molecules may
enter a degradative pathway, whereas a higher proportion
of wtFc molecules are transcytosed or recycled. Consis-
tent with this hypothesis, we observed a greater amount
of hdFc in both lysosomal (LAMP-2 positive) and early
endosomal (EEA1 positive) compartments as compared to
wtFc (Figure 7), suggesting that more wtFc than hdFc is
transported to compartments downstream of the early
endosomes and that less wtFc than hdFc is sent to
degradative compartments. The quantitative colocalization
experiments were conducted using a ligand concentration
of 1 mM, a concentration at which roughly equal amounts
of wtFc and hdFc are bound and transported by rFcRn-
expressing MDCK cells (Figure 6A–C). Under these con-
ditions, we presume that all wtFc or hdFcmolecules on the
cell surface are initially bound by a single rFcRn molecule
prior to internalization and that the amount of each ligand
entering the cell is approximately equal. Consistent with
this assumption, digital image analysis shows that the
average mean pixel intensities for Fc fluorescence in all
images used in these experiments are similar (seeMateri-
als and Methods). Therefore, the higher proportion of hdFc
seen in LAMP-2- and EEA1-positive structures is not the
result of greater absolute amounts of hdFc entering into
the cell. Instead, the data are consistent with a model
whereby equal amounts of both wtFc and hdFc initially
enter the cell but, subsequent to internalization and
delivery to EEA1-positive early endosomes, a greater pro-
portion of wtFc than hdFc molecules remain bound to
FcRn and are transported to downstream compartments
involved in transcytosis and/or recycling. Conversely, a
greater proportion of hdFc molecules remain in early endo-
somes prior to being transferred to the lysosomal degra-
dation pathway along with other fluid-phase components.
This model is also supported by our demonstration that,
following internalization of a single cohort of wtFc or hdFc
ligand, a higher percentage of hdFc is released from rFcRn-
MDCK cells as degraded (acid-soluble) material (Figure 7D).
The observation that an Fc ligand containing only one
FcRn-binding site is preferentially trafficked to lysosomes
and degraded compared with a bivalent Fc ligand can be
explained by an avidity effect; because the hdFc cannot be
cross-linked by adjacent FcRn molecules, it is predicted to
dissociate more readily from FcRn inside endosomes, and
unbound hdFc could then enter a default degradative
pathway with other molecules in the fluid phase. The
present demonstration that FcRn-mediated transcytosis
and recycling of hdFc occur, although at a lower efficiency
than transcytosis and recycling of wtFc, does not address
whether an oligomeric structure of FcRn dimers linked by
homodimeric Fc or IgG molecules (10,11) is present inside
endosomes, but rules out that it is required for proper
transport of vesicles containing FcRn–IgG or FcRn–Fc
complexes.
Materials and Methods
Construction of expression vectors
The gene encoding rFcRnwasmodified by polymerase chain reaction (PCR)
to incorporate 50 Asp718 and 30 HindIII restriction sites and subsequently
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subcloned with an Asp718/HindIII double digest into the mammalian cell
expression vector pCB6-HindIII (kindly provided by Ira Mellman, Yale
University), which carries a neomycin resistance gene for G418 selection.
To make the FcRn–GFP fusion construct, the enhanced GFP (EGFP) gene
was amplified from the pEGFP-1 vector (Clontech, Mountain View, CA,
USA) via PCR to remove the start codon and to introduce a 50 in-frame XhoI
site and a 30 HindIII site and subcloned into the pBluescript II SK vector
(Stratagene, La Jolla, CA, USA). Polymerase chain reaction was used to
introduce a 50 Asp718 site and an in-frame 30 XhoI site at the 30 end of the
rFcRn gene, which was then subcloned into the EGFP Bluescript vector.
The resulting open reading frame, which encoded the entire rFcRn amino
acid sequence, a leucine-glutamate linker region and EGFP without its
N-terminal methionine, was subcloned with a Asp718/HindIII double digest
into the expression vector pCB6-HindIII. We used a previously described
rb2m expression vector (39), which does not contain a selectable marker, to
coexpress rb2m along with full-length rFcRn and the rFcRn-GFP chimeric
protein.
Antibodies
The mouse monoclonal antibodies 1G3 (anti-rFcRn heavy chain) and 4C9
(anti-rb2m) were generated in our laboratory (40) and can be purchased from
the American Tissue Culture Collection. 2B10C11, a mouse monoclonal
antibody against rb2m, was the kind gift of Lennart Lo¨gdberg. 1G3, 4C9 and
2B10C11 were directly conjugated to AlexaFluor488-NHS, AlexaFluor546-
NHS or AlexaFluor633-NHS (Molecular Probes, Carlsbad, CA, USA) accord-
ing to the manufacturer‘s protocol and used for immunofluorescence (1G3
and 4C9) and flow cytometry (2B10C11) experiments. Labeled antibodies
were separated from unconjugated dye using 10 000-kDa cutoff dextran
desalting columns (Pierce, Rockford, IL, USA), and the concentration and
degree of labeling were determined spectrophotometrically using an extinc-
tion coefficient at 280 nm of 202 000 M1 cm1 for the antibodies. A poly-
clonal rabbit antiserum used for Western blotting was raised against purified
rFcRn/rb2m heterodimers. Polyclonal rabbit anti-ZO1 was from Zymed (San
Francisco, CA, USA). Mouse monoclonal anti-EEA1 was from BD Trans-
duction Labs (San Jose, CA, USA), and themouse monoclonal antibody AC17
against the canine lysosomal membrane protein lamp-2 (41,42) was a kind gift
from Dr E. Rodriguez-Boulan (Weill Medical College, Cornell University).
AlexaFluor488-, 546-, and 647-labeled secondary antibodies (goat anti-mouse,
goat anti-rabbit and goat anti-rat) were purchased from Molecular Probes.
Maintenance and transfection of cell lines
MDCK type II cells (generously provided by Keith Mostov, UCSF) were
maintained in MEM (GibcoBRL, Carlsbad, CA, USA) supplemented with
10% FBS (HyClone, Logan, UT, USA) at 378C, 5% CO2. Cells were fed
every other day and passaged once weekly. MDCK II cells were cotrans-
fected with expression vectors encoding full-length rFcRn or rFcRn-GFP
and rb2m using Lipofectamine 2000 (Invitrogen, Carlsbad, CA, USA) and
selected with 0.5 mg/mL G418 (Invitrogen). Resistant colonies were tested
for uptake of fluorescently labeled rat Fc at pH 6.0. Colonies from each
transfection were picked with cloning cylinders and expanded for further
analysis. Colonies were analyzed by flow cytometry for binding to
Alexa488-conjugated 1G3 (anti-rFcRn) (40) and/or Alexa633-conjugated
2B10C11 (anti-rb2m). At least three clones from each transfection were
assayed by immunofluorescence for expression of both the heavy and light
chains of rFcRn as well as for the ability to endocytose and transcytose
radiolabeled rat Fc at acidic pH. We also generated MDCK II cells trans-
fected with the pCB6H vector lacking an inserted gene to serve as
a negative control (vector-only MDCK cells). All cell lines were maintained
under constant drug selection.
The integrity of filter-grown, cell-transfected MDCK monolayers was
evaluated by seeding cells at superconfluent density on filter supports
and recording daily measurements of the TEER. The TEER typically
plateaued after 3 or 4 days at 250–300 Vcm2, a characteristic range for
polarized MDCK II cells (43).
For experiments requiring polarized cell monolayers, cells were seeded at
superconfluent density (1  106 cells/mL) onto 12-mm Transwell polyester
filters (Corning Costar, Acton, MA, USA), with 0.5 and 1.5 mL of media in
the apical and basolateral reservoirs, respectively. Cells were fed daily
beginning 2 days after initial seeding and used for experiments on the
fourth or fifth day postplating.
Western blot and IgG binding analyses
Western blot analyses to evaluate FcRn expression were performed after
denaturing lysis of transfected cells by boiling in 0.5% SDS and vortexing.
After centrifuging to remove insolublematerial, samples of each lysate [10 mg
of total protein as determined by bicinchoninic acid (BCA) assay from Pierce]
were loaded onto a 15% SDS polyacrylamide gel and run under reducing
conditions. Proteins were transferred to nitrocellulose, probed with a 1:2000
dilution of a polyclonal rabbit antiserum against the rFcRn ectodomain and
then treatedwith peroxidase-conjugated goat anti-mouse secondary antibody
(Jackson Immunoresearch Laboratories,West Grove, PA, USA) and detected
by enhanced chemiluminescence (Amersham, Piscataway, NJ, USA).
For evaluations of IgG binding, cells were lysed in 5 mg/mL 3-[(3-
Cholamidopropyl)dimethylammonia]-1-propanesulfonate (CHAPS), 130 mM
NaCl, 20 mM ethylenediaminetetraacetic acid (EDTA), pH 5.9 (15 mM 2-
(N-Morpholino)ethanesulfonic acid [MES]) or pH 8.0 (15 mM 4-(2-
Hydroxyethyl)piperazine-1-ethanesulfonic acid [HEPES]), supplemented with
a protease inhibitor cocktail for mammalian cells (Sigma, St Louis, MO, USA).
After centrifuging to remove insoluble material, lysates were incubated
with 50 mL human IgG-Sepharose (Amersham) pre-equilibrated to pH 5.9 or
pH 8.0 in lysis buffer overnight at 48C. The complexes were washed four
times with 1 mg/mL CHAPS, 30 mM NaCl, 20 mM EDTA, pH 5.9 or 8.0.
Bound proteins were eluted by boiling in double-strength sample buffer and
processed for SDS-PAGE and Western blotting to detect rFcRn as
described above.
Preparation of FcRn ligands for uptake and
transport assays
Rat FcRn binds all four subclasses of rat, human and mouse IgGs with
roughly equal affinities (44); therefore, IgGs and Fcs from these three
species were used for different experiments based on availability or
convenience.
Three forms of rat Fc, wtFc, hdFc and nbFc, were expressed in Chinese
hamster ovary (CHO) cells and purified as previously described (45). The Fc-
expressing CHO cell line was generated by transfection of expression
vectors encoding wtFc (rat IgG2a residues 223–447) and nbFc (IgG2a
residues 223–447 with mutations that disrupt FcRn binding (Thr-252 to Gly,
Ile-253 to Gly, Thr-254 to Gly, His-310 to Glu, His-433 to Glu and His-435 to
Glu) and a C-terminal factor Xa cleavage site and 6x-His tag). The hdFc and
nbFc were purified from supernatants of CHO cells secreting a mixture of
wtFc, hdFc and nbFc as described (24). Briefly, CHO supernatants were
first passed over a nickel-nitrilotriacetic acid (Ni-NTA) column, allowing
separation of wtFc from 6x-His tagged species. The hdFc and nbFc were
eluted from the Ni-NTA column, then passed over an FcRn affinity column
at pH 6.0. The hdFc was eluted from the FcRn column at pH 8.0, and nbFc
was recovered from the flowthrough.
Human Fc and rat and human IgGs, each a mixture of the four IgG sub-
classes, were purchased from Jackson Immunoresearch Laboratories.
Purified samples of the monoclonal antibodies 12C7 (anti-Drosophila
methuselah) and 1C5 (anti-Zn-a2-glycoprotein) (46) were used as mouse
IgG1 proteins. Rat serum albumin was purchased from Sigma. All proteins
were passed over a Superdex 200 gel filtration column (Amersham) to
remove oligomeric species prior to experiments.
Human IgG, rat IgG, mouse IgG1 monoclonal antibodies, human Fc, the
recombinant rat Fcs (wtFc, hdFc and nbFc) and RSA were iodinated to
a specific activity of 2–5 mCi/mg using Na[125I] (MP Biomedicals, Irvine, CA,
USA) and IODO-GEN (Pierce). Radiolabeled ligands were buffer exchanged
into HEPES buffered saline (25 mM HEPES, 150 mM NaCl, pH 7.4) by two
subsequent passages over Bio-Spin 30 prepacked acrylamide columns
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(30 000 molecular weight cutoff) (BioRad, Hercules, CA, USA). Protein
concentrations were determined by BCA assay (Pierce) using bovine serum
albumin or bovine g-globulin as standards.
Quantitative endocytosis assay
Cells were grown in 12-well tissue culture plates until 80–90% confluent.
Prior to incubations with ligand, the cells were serum starved for 20–30 min
in Hanks’ balanced salt solution, 1.3 mM CaCl2, 0.8 mM MgSO4 (HBSSþ)
adjusted to either pH 5.9 or pH 8.0 with MES or HEPES (10 mM each),
respectively. [125I]wtFc was added to a final concentration of 20 nM in
HBSSþ pH 5.9, and plates were incubated in a 378C circulating water bath
for the indicated amounts of time. For competitor studies, 10 mMunlabeled
wtFc or rat IgG was added during the preincubation. The cells were cooled
on ice, washed four times with ice-cold HBSSþ pH 8.0 to remove surface-
bound ligand and then lysed in 0.1 N NaOH. The radioactivity present in the
lysates was counted on a Beckman 5500 g-counter and converted to
fmoles of protein using the specific activity of the radiolabeled ligand.
Quantitative endocytosis assays involving [125I]RSA were done as de-
scribed above, except that the concentrations of [125I]RSA and unlabeled
RSA were 3 mM and 2 mM, respectively, and the incubations were per-
formed at pH 5.0.
Cell-surface binding assay
For assays of Fc binding to cell-surface FcRn, subconfluent rFcRn-MDCK
cells were lifted from plates by incubating in calcium/magnesium-free
HBSS and 4 mM EDTA. Cells were washed twice in binding buffer
(HBSSþ/1% ovalbumin/1 mM KI/10 mM MES, pH 5.9), and triplicate
samples of 500 000 cells were incubated with serial threefold dilutions
of radiolabeled Fc (0.4–900 nM) in a 100 mL volume for 1 h at 48C with
shaking. The binding reactions were collected onto a 96-well filter plate
(Durapore membrane, 0.65- mm pore size) (Millipore, Billerica, MA, USA) by
centrifugation at 1500  g for 1 min. The filter wells were washed four
times with 250 mL of binding buffer at pH 5.9, and the filter circles were
punched out into glass vials and counted for radioactivity. A duplicate set of
binding reactions performed in parallel were washed four times with
HBSSþ/1% ovalbumin/1 mM KI/10 mM HEPES, pH 8.0, to serve as
a control for non-specific binding. The amount of radioactivity bound to
samples washed at pH 8 was subtracted from the corresponding values for
samples washed at acidic pH to yield values for specific binding of the
radiolabeled ligand.
The RSA binding assays were conducted as described above, except
that the binding reactions were performed at pH 5.0 and washed at pH 5.0
or 8.0 (control experiments), and the concentration of [125I]RSA ranged
from 4 nM to 10 mM.
Radioligand transcytosis and recycling assays
For transport assays involving only Fc (Figure 4A), we used radiolabeled rat
wtFc. For assays comparing IgG and Fc transport, we used radiolabeled
human IgG and human Fc (Figure 4B) because radiolabeled human IgG was
transported more efficiently than radiolabeled versions of either rat IgG or
two different mouse monoclonal antibodies (data not shown). Human IgG
binds as well as rat IgG to rFcRn (44).
For transcytosis experiments involving IgG and Fc ligands, polarized cell
monolayers were washed once with HBSSþ/1% ovalbumin/1 mM KI
buffered to pH 5.9 (loading surface) or pH 8.0 (nonloading surface or
loading surface for pH 8 control experiments). Filters were preincubated for
20 min with HBSSþ pH 5.9 on the loading surface (or pH 8.0 for control
experiments) and HBSSþ pH 8.0 on the nonloading surface. For compe-
tition experiments, the unlabeled competing ligand was present in the
loading surface medium during the preincubation step. [125I]Fc (rat or
human) or [125I]IgG (rat or human) was added directly to the loading media
to a final concentration of 20 nM at pH 5.9 or 8.0. Plates were incubated
for 90 min in a 378C circulating water bath, after which media from the
nonloading surface were collected and precipitated at 48C with 10%
(vol/vol) trichloroacidic acid (TCA). The TCA-insoluble (intact ligand) fractions
were counted on a Beckman 5500 g-counter. For experiments comparing the
relative transport efficiencies of [125I]wtFc, -hdFc or -nbFc, the radiolabeled
proteins were added at concentrations ranging from 0.15 nM to 10 mM. The
amount of [125I]nbFc that moved across the monolayers for a given concen-
tration was assumed to represent non-specific transport or leakage across
the monolayer and was subtracted from the corresponding values for wtFc
and hdFc to yield values for specific rFcRn-mediated transport.
Quantitative transcytosis assays involving [125I]RSA were done as de-
scribed above, except that the concentration of [125I]RSA was 10 mM,
and the apical surface was maintained at pH 5.0 or at pH 8.0 (control
experiments). Filters incubated with 30nM [125I]nbFc at pH 5.0 served as
a control for the integrity of themonolayer, and filters incubated with 30 nM
[125I]wtFc at pH 5.0 served as a positive control for the ability of the cells to
function in FcRn-mediated transcytosis at pH 5.0.
For apical recycling experiments involving labeled Fcs, filter-grown mono-
layers were washed and preincubated as described above for the IgG and
Fc transcytosis assays. [125I]labeled wtFc, hdFc or nbFc was added to the
apical surface at pH 5.9 at concentrations ranging from 0.15 nM to 10 mM,
while the basolateral surface was maintained at pH 8.0. After a 30-min
incubation at 378C, the cells were cooled on ice and washed rapidly five
times with ice-cold HBSSþ pH 8.0. Prewarmed HBSSþ pH 8.0 was then
added to the apical and basolateral surfaces. After a 60-min incubation at
378C, media from the apical surface were collected and TCA precipitated,
and the TCA-insoluble fractions were counted as described above.
Analyses of data for binding and transport assays
The amount of specifically bound or transported Fcwas plotted as a function
of concentration, and nonlinear regression analyses of the data were
performed using GraphPad Prism version 4.0b for Macintosh (GraphPad
Software, San Diego, CA, USA). As previously described for biosensor-
based binding data (24), half-maximal binding (KD), transcytosis (T1/2max) or
recycling (R1/2max) values were derived by fitting the wtFc data to a two-site
model, which assumes two independent classes of receptors (a high-
affinity class and a low-affinity class), and the hdFc data to a one-site model.
Preparation of samples for
immunofluorescence experiments
Cells were grown on permeable filter supports for 3–4 days to allow
formation of a polarized monolayer. The filters were preincubated in
HBSSþ pH 8.0 for 20–30 min. The loading surface was then washed with
HBSSþ pH 5.9, and ligands were added to the loading surface at the
indicated concentrations in the same buffer. The nonloading surface was
maintained in HBSSþ pH 7.4 throughout the experiment. Filter plates were
incubated at 378C in a circulating water bath for the indicated times after
which the cells were placed on ice and processed for immunofluorescence.
For immunofluorescence staining, cells were washed briefly with ice-cold
PBSþ (PBS supplemented with 1 mM CaCl2, 0.5 mMMgCl2 and 0.25 mM
MgSO4) and fixed using a pH-shift protocol (47). Briefly, cells were
incubated for 5 min at room temperature in 4% paraformaldehyde (PFA)
in 80 mM 1,4-piperazinebis-(ethanesulphonic acid) (PIPES), pH 6.5, 5 mM
EGTA and 2.0 mM MgCl2, and then transferred to 4% PFA, 100 mM
sodium borate, pH 11.0 for 10 min. After quenching excess aldehyde with
freshly prepared 75 mM NH4Cl and 20 mM glycine in PBS for 10 min, the
cells were washed twice with PBS and blocked for 30 min at room
temperature in PBS containing 8% normal goat serum and 0.025%
saponin. Cells were then incubated overnight at 48C in blocking buffer
containing one or more of the following primary antibodies: fluorescently
conjugated 1G3 or 4C9 (5 mg/mL), mouse anti-EEA1 (1:100 dilution), rabbit
anti-ZO1 (1:25 dilution) or AC17 (1:500). Cells were washed and then
incubated with the appropriate AlexaFluor-conjugated secondary antibodies
diluted 1:500 in blocking buffer for 1 h at room temperature. For experi-
ments involving localization of internalized Fc proteins, unlabeled ligands
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were detected after internalization using AlexaFluor-conjugated goat anti-
rat IgG antibodies. After extensive washing with PBS, cells were treated
with 0.1% Triton X-100 for 5 min, washed once with PBS and then
postfixed with 4% PFA in 100 mM sodium cacodylate, pH 7.4 for 30 min
at room temperature. The cells were washed twice more with PBS, and the
filters were cut out of their holders using a scalpel and a fine-tipped pair of
forceps. Excised filters were mounted on glass slides using ProLong Gold
antifade medium (Molecular Probes), sealed with beeswax and stored at
208C until viewing on a confocal microscope.
Confocal microscopy
All experiments were conducted using an inverted Zeiss LSM META
confocal microscope equipped with a Zeiss Plan-Apochromat 100 oil
objective (numerical aperture 1.4). Green fluorophores were excited with
the 488-nm line of an argon ion laser. Orange and far-red dyes were excited
with the 543 and 633- nm lines of a He-Ne laser, respectively. Fluorescence
was detected through a variable confocal pinhole set to 1.0 Airy units for the
longest wavelength used within a given experiment, and the pinholes of
other channels were adjusted to maintain a constant optical section
thickness across all channels. The gain and offset of the photomultipliers
was adjusted for each channel individually so that the observed fluores-
cence signal filled the linear range of the detectors, with the background
being slightly positive and saturation being minimized.
Image processing and quantitative
colocalization studies
Image processing was performed using the Zeiss LSM Examiner software
(version 3.2). Quantitative colocalization measurements were performed
using the colocalization tool within the Zeiss LSM Examiner package. Four
colocalization experiments were conducted: wtFc with EEA1 and with
AC17, and hdFc with EEA1 and with AC17. For each experiment, we
analyzed five optical sections from approximately five different regions,
each containing 5–10 cells. Different optical sections within the same
region were spaced 2 mm apart to ensure that each represented a unique
image plane within the volume. Thresholds for the two channels in each
image were set to be 2 standard deviations above the mean pixel intensity.
Weighted colocalization coefficients (M) were calculated by summing the
intensities of the above-threshold Fc-positive pixels that colocalized with
above-threshold marker-positive pixels and dividing that number by the sum









where Fci,coloc represents the intensity of a colocalized above-threshold
pixel in the Fc channel, and Fci,total represents the intensity of any above-
threshold pixel in the Fc channel. The value of M can range from 0 (no
colocalization) to 1.0 (all pixels colocalize). The mean intensities of the
labeled proteins were calculated to rule out that potential differences in
colocalization coefficients resulted from higher levels of one labeled pro-
tein relative to another. The mean intensity values were wtFc and hdFc in
the EEA1 colocalization: 1969  342 and 2055  713; wtFc and hdFc in the
lamp-2 colocalization: 2088  476 and 2346  436; EEA1 in the wtFc and
hdFc colocalizations: 1472  414 and 1332  454; lamp-2 in the wtFc and
hdFc colocalizations: 1473  629 and 1433  396.
Degradation assay
The apical surface of rFcRn-MDCK monolayers were incubated for 1 h with
1 mM [125I]labeled wtFc or hdFc at pH 5.9 as described for the immunoflu-
orescence and transcytosis assays. Cells were cooled on ice and then
washed four times with ice-cold pH 8.0 buffer. Prewarmed pH 8.0 buffer
was added, and the cells were returned to 378C for various times, after
which cells were again cooled on ice. Media from the apical and basolateral
surfaces were pooled and TCA precipitated, and the levels of radioactivity in
TCA-soluble and TCA-insoluble fractions were determined. Cell-associated
radioactivity was determined after lysis of cells in 0.1 N NaOH. The percent
of an Fc ligand that was degraded at each time point was derived as
[c.p.m.TCA-soluble/(c.p.m.TCA-soluble þ c.p.m.TCA-insoluble þ c.p.m.cell-associated)]
 100.
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